POINT BIOPHARMA GLOBAL INC shareholders Q2 2023

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2023. The put-call ratio across all filers is 128.31 and the average weighting 0.2%.

POINT BIOPHARMA GLOBAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
US BANCORP \DE\ 15,710$142,3330.00%
BANK OF AMERICA CORP /DE/ 157,618$1,428,0180.00%
WELLS FARGO & COMPANY/MN 74,358$673,6830.00%
JANE STREET GROUP, LLC 14,582$132,1130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 63,176$572,3750.00%
Legal & General Group Plc 56,977$516,2120.00%
PRICE T ROWE ASSOCIATES INC /MD/ 26,973$2450.00%
NEW YORK STATE COMMON RETIREMENT FUND 26,958$2440.00%
CITIGROUP INC 81,862$741,6690.00%
Fisher Asset Management, LLC 99,189$898,6520.00%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 18,538$134,7710.00%
OSAIC HOLDINGS, INC. 891$8,0680.00%
ALLIANCEBERNSTEIN L.P. 130,450$1,181,8770.00%
PRINCIPAL FINANCIAL GROUP INC 25,468$230,7400.00%
LAZARD ASSET MANAGEMENT LLC 15,627$1400.00%
Aquatic Capital Management LLC 600$50.00%
ProShare Advisors LLC 11,768$106,6180.00%
Beutel, Goodman & Co Ltd. 7,174$640.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 11,114$100,6930.00%
External links

This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q2 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.